comparemela.com

Latest Breaking News On - Hyaluronidase based - Page 1 : comparemela.com

sBLA Submitted to FDA for Subcutaneous Daratumumab Plus VRd in Transplant-Eligible Multiple Myeloma

A sBLA seeking the approval of D-VRd for transplant-eligible patients with newly diagnosed multiple myeloma was submitted to the FDA.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.